drugset / Trial / NCT01401803
Brow Lifting With Dysport
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to provide data to assess Dysport™ injections as a treatment therapy for brow ptosis. This study will assess the outcome of brow lifting with use of Dysport.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-07
- Completion
- 2012-12
Publications
- Results Flynn TC, Carruthers JA, Carruthers JA, Clark RE 2nd. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study. Dermatol Surg. 2003 Sep;29(9):943-50; discussion 950-1. doi: 10.1046/j.1524-4725.2003.29257.x.
- Results Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, Walker P, Eadie N; BOTOX Glabellar Lines I Study Group. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002 Jun;46(6):840-9. doi: 10.1067/mjd.2002.121356.
- Results Carruthers A, Carruthers J, Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg. 2005 Apr;31(4):414-22; discussion 422. doi: 10.1111/j.1524-4725.2005.31107.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 10 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 20 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 50 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 60 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 70 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 80 iu | Intramuscular |